[Molecular targetting therapy for non-small-cell lung neoplasms with EGF-R inhibitors].
Yano
Seiji
S
Muguruma
Hiroaki
H
Sone
Saburo
S
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000378:metabolism; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011799:Quinazolines / Q000494:pharmacology* / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000068818:Cetuximab; D000077156:Gefitinib